Moderna laid out plans Thursday to slash future costs in an effort to stop bleeding cash, but a worsening political ...

The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and ...

Moderna Inc. shares declined after the company’s first-quarter vaccine sales missed estimates and it disclosed a delay in the ...

Kennedy and FDA Commissioner Marty Makary’s approach to assessing vaccines could put Covid boosters out of reach.

Jefferies analysts said Moderna’s first quarter was “in line,” with a miss on revenue offset by a beat on earnings per share.

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

Public health experts worry the policy change would not only cast doubt on the safety and effectiveness of vaccines but would limit production and access. Separately, a decades-long pursuit of ...

UB researchers have compiled a list of words physicians should never say to patients with complex, chronic disorders that are ...

According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...

How have the wild initial months of Donald Trump’s return to the White House landed on Washington? We asked the people who ...

Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

The department did not confirm which vaccines the testing would be applied to or how the change would be implemented.